Related Experiment Video
Updated: Jan 24, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
[Viral hepatitis and pregnancy].
Imane Ben M'Barek1, Jeanne Sibiude2, Élise Bouthry3
1Université aris Cité, ervice de ynécologieobstétrique, Beaujon, AP-HP, FETUS URP 7328, Clichy, France.
Viral hepatitis in pregnancy presents varied risks. Hepatitis B management includes screening and antivirals to prevent mother-to-child transmission, while other types like Hepatitis E pose severe risks.
Area of Science:
- Hepatology
- Obstetrics
- Infectious Diseases
Background:
- Viral hepatitis encompasses several distinct viruses (A, B, C, D, E) with varying transmission routes and clinical impacts.
- Pregnancy can alter the course of viral hepatitis, increasing risks for both the mother and the fetus.
- Understanding the specific risks associated with each hepatitis type during pregnancy is crucial for effective management.
Purpose of the Study:
- To review the impact of different viral hepatitis types on pregnancy outcomes.
- To outline the risks of obstetric complications and vertical transmission for each hepatitis virus.
- To summarize current management strategies, including screening and treatment, for viral hepatitis during pregnancy.
Main Methods:
- Literature review of viral hepatitis in pregnancy.
- Analysis of transmission routes, obstetric complications, and vertical transmission risks for Hepatitis A, B, C, D, and E.
- Summary of management guidelines, including prenatal screening and antiviral therapies.
Main Results:
- Hepatitis A: Generally mild, but may increase obstetric complication risk.
- Hepatitis B: Most common, significant mother-to-child transmission risk, managed with screening and antivirals.
- Hepatitis C: Primarily blood-borne, implications for pregnancy discussed.
- Hepatitis D: Superinfects Hepatitis B, limited pregnancy treatment options.
- Hepatitis E: Severe in third trimester, risk of fulminant hepatitis, rare mother-to-child transmission.
- Overall, mother-to-child transmission is rare, and breastfeeding is generally permissible.
Conclusions:
- The clinical presentation and risks of viral hepatitis during pregnancy are type-specific.
- Proactive management, including screening and targeted therapies (especially for Hepatitis B), is essential to mitigate risks.
- Further research may be needed for Hepatitis D management in pregnant populations.
Related Concept Videos
Viral Recombination
Viral Structure
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Viral Mutations

